Quantcast

New England Peptide, Inc. and Cambridge Isotope Laboratories, Inc. Announce Quantitative Proteomics Manufacturing Collaboration

July 16, 2013

New England Peptide, Inc. (NEP) and Cambridge Isotope Laboratories, Inc. (CIL) announced a joint manufacturing and marketing agreement of pre-loaded resins for the synthesis of peptide stable isotope standards (SIS) for quantitative proteomics.

Gardner, MA (PRWEB) July 16, 2013

New England Peptide, Inc. (NEP) and Cambridge Isotope Laboratories, Inc. (CIL) announced a joint manufacturing and marketing agreement of pre-loaded resins for the synthesis of peptide stable isotope standards (SIS).

Under the terms of the agreement CIL will provide high purity stable isotope amino acids to NEP and NEP will load the isotopologues onto peptide synthesis resins, perform quality control on the resins, and redistribute to CIL. Both companies have agreed to co-market and sell the pre-loaded resins to peptide synthesis laboratories worldwide.

"We saw this collaboration as an important way to facilitate the synthesis of peptide stable isotope standards (SIS). This product will increase the availability and decrease the cost of SIS peptides, which will help the quantitative proteomics field grow", commented Sam Massoni, President and CEO of New England Peptide, Inc.

The gold standard for MS-based quantitative methods is to use a mass-shifted, stable-isotope-labeled peptide standard spiked into the sample of interest, which then allows quantification from a simple ratio of the labeled peak height to the unlabeled. This collaboration is further evidence of NEP and CIL’s commitment to the field.

"We were the first company to manufacture protected stable isotope labeled amino acids at 99% isotopic enrichment. NEP was one of the reasons we have been expanding our production of these 99% enriched reagents. NEP requested the highest quality reagents to meet the increased demand of SIS peptides, and we met that need. This collaboration is a natural fit for both companies and adds value to both product lines", commented Maureen Duffy, VP of Sales and Marketing at Cambridge Isotope Laboratories, Inc.

NEP is one of the premier peptide synthesis companies.

About New England Peptide (NEP)

New England Peptide, founded in 1998, designs and manufactures peptides and polyclonal antibodies for drug and vaccine discovery organizations worldwide. Headquartered in the Boston metro area in Gardner, MA., the company’s chemists and immunological experts specialize in delivering a full range of services for biotech and pharmaceutical applications. NEP is a worldwide leader in providing SIS peptides for the quantitative proteomics field. More information on NEP can be found at http://www.newenglandpeptide.com.

About Cambridge Isotope Laboratories, Inc. (CIL)

CIL is the world’s leading manufacturer of stable isotope labeled reagents for research applications in proteomics, genomics, molecular biology, metabolic research, clinical and diagnostic research and ultra trace environmental analysis. For over 30 years CIL has provided over 15,000 different research compounds to its base of over 35,000 medical, pharmaceutical, academic and government customers.

CIL corporate headquarters are located in Tewksbury, MA. More information on CIL can be found at http://www.isotope.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10920006.htm


Source: prweb



comments powered by Disqus